133 related articles for article (PubMed ID: 2162147)
1. Antiherpes virus activity and effect on deoxyribonucleoside triphosphate pools of (E)-5-(2-bromovinyl)-2'-deoxycytidine in combination with deaminase inhibitors.
Aduma PJ; Gupta SV; De Clercq E
Antiviral Res; 1990 Mar; 13(3):111-25. PubMed ID: 2162147
[TBL] [Abstract][Full Text] [Related]
2. Regulatory effects of deoxyribonucleosides on the activity of 5-methoxymethyl-2'-deoxycytidine: modulation of antiherpes activity by deoxyguanosine and tetrahydrodeoxyuridine.
Aduma PJ; Gupta SV; Stuart AL; Tourigny G
Antiviral Res; 1991 May; 15(4):301-13. PubMed ID: 1659312
[TBL] [Abstract][Full Text] [Related]
3. Deoxyribonucleoside triphosphate pools of herpes simplex virus infected cells: the influence of selective antiherpes agents and the role of the deaminase pathway.
Aduma PJ; Gupta SV; Stuart AL; Tourigny G
Biochem Cell Biol; 1991; 69(5-6):409-14. PubMed ID: 1654943
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of E-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil on herpes simplex virus replication and DNA synthesis.
Descamps J; Sehgal RK; De Clercq E; Allaudeen HS
J Virol; 1982 Jul; 43(1):332-6. PubMed ID: 6287008
[TBL] [Abstract][Full Text] [Related]
5. Modulation of deoxynucleotide metabolism by the deoxycytidylate deaminase inhibitor 3,4,5,6-tetrahydrodeoxyuridine.
Heinemann V; Plunkett W
Biochem Pharmacol; 1989 Nov; 38(22):4115-21. PubMed ID: 2688654
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, molecular conformation and activity against herpes simplex virus of (E)-5-(2-bromovinyl)-2'-deoxycytidine analogs.
Zoghaib WM; Mannala S; Gupta VS; Tourigny G
Nucleosides Nucleotides Nucleic Acids; 2012 Apr; 31(4):364-76. PubMed ID: 22444197
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate potentiates anti-herpes simplex virus type 1 activity of E-5-(2-bromovinyl)-2'-deoxyuridine.
Pancheva SN
Acta Virol; 1995 Apr; 39(2):117-9. PubMed ID: 7676937
[TBL] [Abstract][Full Text] [Related]
8. Deoxyribonucleoside triphosphate pools in cells infected with deoxypyrimidine kinaseless herpes simplex virus.
Jamieson AT; Bjursell G
J Gen Virol; 1976 Apr; 31(1):115-23. PubMed ID: 177723
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of E-5-(2-halovinyl)-2'-deoxyuridines into deoxyribonucleic acids of herpes simplex virus type 1-infected cells.
Allaudeen HS; Chen MS; Lee JJ; De Clercq E; Prusoff WH
J Biol Chem; 1982 Jan; 257(2):603-6. PubMed ID: 6274855
[TBL] [Abstract][Full Text] [Related]
10. On the mechanism of selective inhibition of herpesvirus replication by (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Allaudeen HS; Kozarich JW; Bertino JR; De Clercq E
Proc Natl Acad Sci U S A; 1981 May; 78(5):2698-702. PubMed ID: 6265902
[TBL] [Abstract][Full Text] [Related]
11. Deoxyribonucleoside triphosphate pools in herpes simplex type 1 infected cells.
Jamieson AT; Bjursell G
J Gen Virol; 1976 Apr; 31(1):101-13. PubMed ID: 177722
[TBL] [Abstract][Full Text] [Related]
12. Can ribonucleotide reductase be considered as an effective target for developing antiherpes simplex virus type II (HSV-2) compounds?
Nutter LM; Grill SP; Cheng YC
Biochem Pharmacol; 1985 Mar; 34(6):777-80. PubMed ID: 2983736
[TBL] [Abstract][Full Text] [Related]
13. Antiherpes activity of some novel analogues of (E)-5-(2-bromovinyl)-2'-deoxyuridine (E-BrVUdR) in two different cell lines.
Reefschläger J; Bärwolff D; Herrmann G; Langen P
Acta Virol; 1984 Jan; 28(1):1-10. PubMed ID: 6143491
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replication.
De Clercq E; Bernaerts R; Merta A; Rosenwirth B
Mol Pharmacol; 1990 May; 37(5):658-64. PubMed ID: 2160059
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Docherty JJ; Dobson AT; Trimble JJ; Jennings BA
Intervirology; 1991; 32(5):308-15. PubMed ID: 1657822
[TBL] [Abstract][Full Text] [Related]
16. The relationship between incorporation of E-5-(2-Bromovinyl)-2'-deoxyuridine into herpes simplex virus type 1 DNA with virus infectivity and DNA integrity.
Mancini WR; De Clercq E; Prusoff WH
J Biol Chem; 1983 Jan; 258(2):792-5. PubMed ID: 6296080
[TBL] [Abstract][Full Text] [Related]
17. Metabolic fate of (E)-5-(2-bromovinyl)-2'-deoxyuridine in herpes simplex virus- and mock-infected cells.
Ayisi NK; De Clercq E; Wall RA; Hughes H; Sacks SL
Antimicrob Agents Chemother; 1984 Nov; 26(5):762-5. PubMed ID: 6097176
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine.
De Clercq E; Desgranges C; Herdewijn P; Sim IS; Jones AS; McLean MJ; Walker RT
J Med Chem; 1986 Feb; 29(2):213-7. PubMed ID: 3005566
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
[TBL] [Abstract][Full Text] [Related]
20. 5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication.
Wigerinck P; Pannecouque C; Snoeck R; Claes P; De Clercq E; Herdewijn P
J Med Chem; 1991 Aug; 34(8):2383-9. PubMed ID: 1652017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
